Sushila R. Dalal to Tumor Necrosis Factor-alpha
This is a "connection" page, showing publications Sushila R. Dalal has written about Tumor Necrosis Factor-alpha.
Connection Strength
0.066
-
Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2020 06; 51(12):1365-1372.
Score: 0.036
-
The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease. Inflamm Bowel Dis. 2018 02 15; 24(3):502-509.
Score: 0.031